Precision Optics Corporation Inc

Precision Optics Corporation Inc(POCI)の株式分析

$4.887

-0.062 (-1.27%)終値時点

Loading chart…
高値
4.930
始値
4.825
出来高加重平均価格
4.88
出来高
9.87K
時価総額
35.15M
安値
4.825
売買代金
48.18K
EV/EBITDA(TTM)
-319.48

Precision Optics Corporation, Inc. is a developer and manufacturer of optical instruments. The Company’s segments include medical devices and advanced defense/aerospace products. Its optical and imaging technology, custom designs, manufacturing capabilities, and engineering and development capabilities have generated traditional endoscopes and endocouplers, digital imaging endoscopes using complementary metal-oxide-semiconductor (CMOS) sensor technology, some designed and manufactured for single-use, as well as other custom imaging and illumination products for our customers’ use in minimally invasive surgical procedures. It designs and manufactures precision endoscopes and microprecision lenses, assemblies and complete medical devices to meet the surgical community’s demand for imaging systems for minimally invasive surgery. Its technologies serve defense / aerospace markets, including applications supporting satellite network communications.

www.poci.com

AI分析 of Precision Optics Corporation Inc (POCI)

買い

Precision Optics Corporation Inc is a good buy right now due to its recent strong revenue growth, with Q3 revenue increasing by 107.1% year-over-year to $8.7 million, and a current price of $4.80, which is significantly below its 52-week high of $6.15. The RSI is at 80.676, indicating strong momentum, although it is approaching overbought levels. The main risk is the negative net income, which was -$103,787 in Q4 2026, but the trend is improving as the company moves towards profitability.

バリュエーション指標

Precision Optics Corporation Inc(POCI)の現在の予想PERは0.00で、5年平均は0.00です。

予想PER

大幅な割安
5年平均 P/E
0.00
現在のP/E
0.00
割高
0.00
割安
0.00

予想EV/EBITDA

適正
5年平均 EV/EBITDA
307.03
現在のEV/EBITDA
-319.48
割高
1354.40
割安
-740.33

予想PSR

大幅な割高
5年平均 P/S
0.17
現在のP/S
1.53
割高
0.64
割安
-0.31

Alphio AI による POCI の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%POCI

$4.83

シナリオ価格

基

基本

基本 · 50%POCI

$4.56

シナリオ価格

弱

弱気

弱気 · 25%POCI

$3.87

シナリオ価格

イベントタイムライン

2026-11-05 (ET)

10:30:00

Precision Optics Receives $2M Aerospace Order

2026-09-17 (ET)

09:30:00

Precision Optics Secures $50,000 Satellite Development Order

2026-09-10 (ET)

09:30:00

Precision Optics Receives $1.3M Follow-On Orders

2026-03-27 (ET)

07:50:00

Lucid Capital Offering Priced Below Last Closing Price of $4.21

2026-03-26 (ET)

16:10:00

Precision Optics Corporation Launches Underwritten Public Offering

ニュース

POCI のよくある質問 — Alphio AI が回答

Precision Optics Corporation, Inc. is a developer and manufacturer of optical instruments. The Company’s segments include medical devices and advanced defense/aerospace products. Its optical and imaging technology, custom designs, manufacturing capabilities, and engineering and development capabilities have generated traditional endoscopes and endocouplers, digital imaging endoscopes using complementary metal-oxide-semiconductor (CMOS) sensor technology, some designed and manufactured for single-use, as well as other custom imaging and illumination products for our customers’ use in minimally invasive surgical procedures. It designs and manufactures precision endoscopes and microprecision lenses, assemblies and complete medical devices to meet the surgical community’s demand for imaging systems for minimally invasive surgery. Its technologies serve defense / aerospace markets, including applications supporting satellite network communications. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Precision Optics Corporation Inc is a good buy right now due to its recent strong revenue growth, with Q3 revenue increasing by 107.1% year-over-year to $8.7 million, and a current price of $4.80, which is significantly below its 52-week high of $6.15. The RSI is at 80.676, indicating strong momentum, although it is approaching overbought levels. The main risk is the negative net income, which was -$103,787 in Q4 2026, but the trend is improving as the company moves towards profitability.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める